ITFG2 is a therapeutic target in ischemic ventricular arrhythmias
Feb. 5, 2025
Myocardial infarction remains one of the leading causes of mortality, which is usually complicated by the occurrence of ischemic ventricular arrhythmias, which in turn increase the risk of sudden cardiac death in patients with myocardial infarction.